Stay updated on TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.4%
    Check dated 2025-06-19T19:46:48.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-05T11:17:41.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.6%
    Check dated 2025-05-29T05:58:46.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-30T13:57:40.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The webpage has been updated to include new drug information related to the treatment of triple negative breast cancer, specifically mentioning Doxorubicin, Epirubicin, Cyclophosphamide, and Granulocyte colony stimulating factor. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    14%
    Check dated 2025-04-16T02:04:59.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 9, 2025.
    Difference
    0.2%
    Check dated 2025-04-08T22:31:57.000Z thumbnail image

Stay in the know with updates to TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.